Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes.
Identifieur interne : 000F57 ( PubMed/Checkpoint ); précédent : 000F56; suivant : 000F58Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes.
Auteurs : Kamel Mohammedi [Australie] ; Mark Woodward [Australie] ; Michel Marre [France] ; Stephen Colagiuri [Australie] ; Mark Cooper [Australie] ; Stephen Harrap [Australie] ; Giuseppe Mancia [Italie] ; Neil Poulter [Royaume-Uni] ; Bryan Williams [Royaume-Uni] ; Sophia Zoungas [Australie] ; John Chalmers [Australie]Source :
- Cardiovascular diabetology [ 1475-2840 ] ; 2017.
Abstract
Microvascular disease is associated with a high risk of macrovascular events in patients with type 2 diabetes, but the impact of macrovascular disease on the risk of microvascular events remains unknown. We sought to evaluate the respective effects of prior microvascular and macrovascular disease on the risk of major outcomes, including microvascular events, in these patients.
DOI: 10.1186/s12933-017-0574-y
PubMed: 28750645
Affiliations:
- Australie, France, Italie, Royaume-Uni
- Angleterre, Grand Londres, Lombardie, Nouvelle-Galles du Sud, Île-de-France
- Londres, Milan, Paris, Sydney
- University College de Londres, Université de Sydney
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:28750645Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes.</title><author><name sortKey="Mohammedi, Kamel" sort="Mohammedi, Kamel" uniqKey="Mohammedi K" first="Kamel" last="Mohammedi">Kamel Mohammedi</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia. kmohammedi@georgeinstitute.org.au.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, NSW</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Woodward, Mark" sort="Woodward, Mark" uniqKey="Woodward M" first="Mark" last="Woodward">Mark Woodward</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, NSW</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Marre, Michel" sort="Marre, Michel" uniqKey="Marre M" first="Michel" last="Marre">Michel Marre</name><affiliation wicri:level="3"><nlm:affiliation>INSERM, UMRS 1138, Centre de Recherche des Cordeliers, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INSERM, UMRS 1138, Centre de Recherche des Cordeliers, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Colagiuri, Stephen" sort="Colagiuri, Stephen" uniqKey="Colagiuri S" first="Stephen" last="Colagiuri">Stephen Colagiuri</name><affiliation wicri:level="4"><nlm:affiliation>Boden Institute of Obesity, Nutrition, Exercise & Eating Disorders, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Boden Institute of Obesity, Nutrition, Exercise & Eating Disorders, Sydney Medical School, University of Sydney, Sydney, NSW</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Cooper, Mark" sort="Cooper, Mark" uniqKey="Cooper M" first="Mark" last="Cooper">Mark Cooper</name><affiliation wicri:level="1"><nlm:affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Baker IDI Heart and Diabetes Institute, Melbourne, VIC</wicri:regionArea><wicri:noRegion>VIC</wicri:noRegion></affiliation></author><author><name sortKey="Harrap, Stephen" sort="Harrap, Stephen" uniqKey="Harrap S" first="Stephen" last="Harrap">Stephen Harrap</name><affiliation wicri:level="1"><nlm:affiliation>The University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC</wicri:regionArea><wicri:noRegion>VIC</wicri:noRegion></affiliation></author><author><name sortKey="Mancia, Giuseppe" sort="Mancia, Giuseppe" uniqKey="Mancia G" first="Giuseppe" last="Mancia">Giuseppe Mancia</name><affiliation wicri:level="3"><nlm:affiliation>The University of Milan-Bicocca and Istituto Auxologico Italiano, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>The University of Milan-Bicocca and Istituto Auxologico Italiano, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author><author><name sortKey="Poulter, Neil" sort="Poulter, Neil" uniqKey="Poulter N" first="Neil" last="Poulter">Neil Poulter</name><affiliation wicri:level="3"><nlm:affiliation>The International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>The International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Williams, Bryan" sort="Williams, Bryan" uniqKey="Williams B" first="Bryan" last="Williams">Bryan Williams</name><affiliation wicri:level="4"><nlm:affiliation>Institute of Cardiovascular Sciences, University College London (UCL) and NIHR UCL Hospitals Biomedical Research Centre, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute of Cardiovascular Sciences, University College London (UCL) and NIHR UCL Hospitals Biomedical Research Centre, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">University College de Londres</orgName></affiliation></author><author><name sortKey="Zoungas, Sophia" sort="Zoungas, Sophia" uniqKey="Zoungas S" first="Sophia" last="Zoungas">Sophia Zoungas</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, NSW</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Chalmers, John" sort="Chalmers, John" uniqKey="Chalmers J" first="John" last="Chalmers">John Chalmers</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, NSW</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28750645</idno><idno type="pmid">28750645</idno><idno type="doi">10.1186/s12933-017-0574-y</idno><idno type="wicri:Area/PubMed/Corpus">000941</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000941</idno><idno type="wicri:Area/PubMed/Curation">000938</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000938</idno><idno type="wicri:Area/PubMed/Checkpoint">000938</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000938</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes.</title><author><name sortKey="Mohammedi, Kamel" sort="Mohammedi, Kamel" uniqKey="Mohammedi K" first="Kamel" last="Mohammedi">Kamel Mohammedi</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia. kmohammedi@georgeinstitute.org.au.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, NSW</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Woodward, Mark" sort="Woodward, Mark" uniqKey="Woodward M" first="Mark" last="Woodward">Mark Woodward</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, NSW</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Marre, Michel" sort="Marre, Michel" uniqKey="Marre M" first="Michel" last="Marre">Michel Marre</name><affiliation wicri:level="3"><nlm:affiliation>INSERM, UMRS 1138, Centre de Recherche des Cordeliers, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INSERM, UMRS 1138, Centre de Recherche des Cordeliers, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Colagiuri, Stephen" sort="Colagiuri, Stephen" uniqKey="Colagiuri S" first="Stephen" last="Colagiuri">Stephen Colagiuri</name><affiliation wicri:level="4"><nlm:affiliation>Boden Institute of Obesity, Nutrition, Exercise & Eating Disorders, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Boden Institute of Obesity, Nutrition, Exercise & Eating Disorders, Sydney Medical School, University of Sydney, Sydney, NSW</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Cooper, Mark" sort="Cooper, Mark" uniqKey="Cooper M" first="Mark" last="Cooper">Mark Cooper</name><affiliation wicri:level="1"><nlm:affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Baker IDI Heart and Diabetes Institute, Melbourne, VIC</wicri:regionArea><wicri:noRegion>VIC</wicri:noRegion></affiliation></author><author><name sortKey="Harrap, Stephen" sort="Harrap, Stephen" uniqKey="Harrap S" first="Stephen" last="Harrap">Stephen Harrap</name><affiliation wicri:level="1"><nlm:affiliation>The University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC</wicri:regionArea><wicri:noRegion>VIC</wicri:noRegion></affiliation></author><author><name sortKey="Mancia, Giuseppe" sort="Mancia, Giuseppe" uniqKey="Mancia G" first="Giuseppe" last="Mancia">Giuseppe Mancia</name><affiliation wicri:level="3"><nlm:affiliation>The University of Milan-Bicocca and Istituto Auxologico Italiano, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>The University of Milan-Bicocca and Istituto Auxologico Italiano, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author><author><name sortKey="Poulter, Neil" sort="Poulter, Neil" uniqKey="Poulter N" first="Neil" last="Poulter">Neil Poulter</name><affiliation wicri:level="3"><nlm:affiliation>The International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>The International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Williams, Bryan" sort="Williams, Bryan" uniqKey="Williams B" first="Bryan" last="Williams">Bryan Williams</name><affiliation wicri:level="4"><nlm:affiliation>Institute of Cardiovascular Sciences, University College London (UCL) and NIHR UCL Hospitals Biomedical Research Centre, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute of Cardiovascular Sciences, University College London (UCL) and NIHR UCL Hospitals Biomedical Research Centre, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">University College de Londres</orgName></affiliation></author><author><name sortKey="Zoungas, Sophia" sort="Zoungas, Sophia" uniqKey="Zoungas S" first="Sophia" last="Zoungas">Sophia Zoungas</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, NSW</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Chalmers, John" sort="Chalmers, John" uniqKey="Chalmers J" first="John" last="Chalmers">John Chalmers</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, NSW</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author></analytic><series><title level="j">Cardiovascular diabetology</title><idno type="eISSN">1475-2840</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Microvascular disease is associated with a high risk of macrovascular events in patients with type 2 diabetes, but the impact of macrovascular disease on the risk of microvascular events remains unknown. We sought to evaluate the respective effects of prior microvascular and macrovascular disease on the risk of major outcomes, including microvascular events, in these patients.</div></front></TEI><pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">28750645</PMID><DateCreated><Year>2017</Year><Month>07</Month><Day>28</Day></DateCreated><DateRevised><Year>2017</Year><Month>08</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1475-2840</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Jul</Month><Day>27</Day></PubDate></JournalIssue><Title>Cardiovascular diabetology</Title><ISOAbbreviation>Cardiovasc Diabetol</ISOAbbreviation></Journal><ArticleTitle>Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes.</ArticleTitle><Pagination><MedlinePgn>95</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12933-017-0574-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Microvascular disease is associated with a high risk of macrovascular events in patients with type 2 diabetes, but the impact of macrovascular disease on the risk of microvascular events remains unknown. We sought to evaluate the respective effects of prior microvascular and macrovascular disease on the risk of major outcomes, including microvascular events, in these patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Participants in the Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Modified-Release Controlled Evaluation (ADVANCE) trial (n = 11,140) and the ADVANCE-ON post-trial study (n = 8494) were categorized into 4 groups at baseline: dual absence of microvascular or macrovascular disease (n = 6789), presence of microvascular disease alone (n = 761), macrovascular disease alone (n = 3196), and both (n = 394). Outcomes were all-cause mortality, major macrovascular events (MACE), and major clinical microvascular events.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">All-cause mortality, MACE, and major clinical microvascular events occurred in 2265 (20%), 2166 (19%), and 807 (7%) participants respectively, during a median follow-up of 9.9 (inter-quartile interval 5.6-10.9) years. The adjusted hazard ratios [95% CI] of death, MACE, and major clinical microvascular events were each greater in patients with baseline microvascular disease (1.43 [1.20-1.71], 1.64 [1.37-1.97], and 4.74 [3.86-5.82], respectively), macrovascular disease (1.43 [1.30-1.57], 2.04 [1.86-2.25], and 1.26 [1.06-1.51]) or both (2.01 [1.65-2.45], 2.92 [2.40-3.55], and 6.30 [4.93-8.06]) compared with those without these conditions. No interaction was observed between baseline microvascular and macrovascular disease for these events. The addition of microvascular disease (change in c-statistic [95% CI] 0.005 [0.002-0.008], p = 0.02) or macrovascular disease (0.005 [0.002-0.007], p < 0.0001) considered separately or together (0.011 [0.007-0.014], p < 0.0001) improved the discrimination and the classification (integrated discrimination improvement (IDI): 0.013 [0.010-0.016], p < 0.001; net reclassification improvement (NRI): 0.021 [0.011-0.032], p < 0.001) of the risk of all-cause mortality. Microvascular disease improved discrimination (0.009 [0.003-0.014]) and classification (IDI: 0.008 [0.006-0.010]; NRI: 0.011 [0.001-0.020]) of MACE. Baseline macrovascular disease modestly enhanced IDI (0.002 [0.001-0.002]) and NRI (0.041 [0.002-0.087]), but not discrimination, of major clinical microvascular events.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Microvascular and macrovascular disease are independently associated with the 10-year risk of death, MACE, and major clinical microvascular events in patients with type 2 diabetes. The coexistence of these conditions was associated with the highest risks.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mohammedi</LastName><ForeName>Kamel</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia. kmohammedi@georgeinstitute.org.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM, UMRS 1138, Centre de Recherche des Cordeliers, Paris, France. kmohammedi@georgeinstitute.org.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Diabetology, Endocrinology and Nutrition, Assistance Publique Hôpitaux de Paris, Bichat Hospital, DHU FIRE, Paris, France. kmohammedi@georgeinstitute.org.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woodward</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The George Institute for Global Health, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marre</LastName><ForeName>Michel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>INSERM, UMRS 1138, Centre de Recherche des Cordeliers, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Diabetology, Endocrinology and Nutrition, Assistance Publique Hôpitaux de Paris, Bichat Hospital, DHU FIRE, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Paris Diderot, Sorbonne Paris Cité, UFR de Médecine, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colagiuri</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Boden Institute of Obesity, Nutrition, Exercise & Eating Disorders, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrap</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mancia</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>The University of Milan-Bicocca and Istituto Auxologico Italiano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poulter</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>The International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Bryan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Cardiovascular Sciences, University College London (UCL) and NIHR UCL Hospitals Biomedical Research Centre, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zoungas</LastName><ForeName>Sophia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Clayton, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chalmers</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>07</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cardiovasc Diabetol</MedlineTA><NlmUniqueID>101147637</NlmUniqueID><ISSNLinking>1475-2840</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Diabetes Obes Metab. 2007 Nov;9(6):781-91</RefSource><PMID Version="1">17924862</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiovasc Diabetol. 2016 Jul 19;15(1):101</RefSource><PMID Version="1">27431507</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2014 Oct 9;371(15):1392-406</RefSource><PMID Version="1">25234206</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetologia. 2001 Sep;44(9):1118-20</RefSource><PMID Version="1">11596665</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2016 Jun 14;133(24):2459-502</RefSource><PMID Version="1">27297342</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Diabetes Endocrinol. 2016 Jul;4(7):588-97</RefSource><PMID Version="1">27216886</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiovasc Diabetol. 2013 Oct 17;12 :152</RefSource><PMID Version="1">24134628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiovasc Diabetol. 2016 Mar 24;15:51</RefSource><PMID Version="1">27013319</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes. 2005 Jun;54(6):1615-25</RefSource><PMID Version="1">15919781</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Endocrinol Metab. 2015 Jul;100(7):2666-72</RefSource><PMID Version="1">25942480</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2005 Jun 7;111(22):2927-34</RefSource><PMID Version="1">15927971</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes Obes Metab. 2016 Mar;18(3):289-94</RefSource><PMID Version="1">26661693</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetologia. 2015 Mar;58(3):505-18</RefSource><PMID Version="1">25512005</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Coll Cardiol. 2016 Mar 15;67(10 ):1158-69</RefSource><PMID Version="1">26965536</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes. 2016 Oct;65(10 ):3129-38</RefSource><PMID Version="1">27352886</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiovasc Diabetol. 2016 Sep 02;15(1):129</RefSource><PMID Version="1">27590190</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2016 Nov 1;134(18):1339-1352</RefSource><PMID Version="1">27678264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes Care. 2016 Oct;39(10):1796-803</RefSource><PMID Version="1">27456835</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cardiovasc Disord. 2014 Nov 19;14:162</RefSource><PMID Version="1">25410473</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiovasc Diabetol. 2013 Oct 05;12 :142</RefSource><PMID Version="1">24093550</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2007 Sep 8;370(9590):829-40</RefSource><PMID Version="1">17765963</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2010 Oct 29;107(9):1058-70</RefSource><PMID Version="1">21030723</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nutr Metab Cardiovasc Dis. 2010 Jan;20(1):72-7</RefSource><PMID Version="1">19747805</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetologia. 2016 Feb;59(2):371-8</RefSource><PMID Version="1">26526662</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiovasc Diabetol. 2011 Aug 03;10 :71</RefSource><PMID Version="1">21812947</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2008 Jun 12;358(24):2560-72</RefSource><PMID Version="1">18539916</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stat Med. 2004 Jul 15;23(13):2109-23</RefSource><PMID Version="1">15211606</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes Care. 2017 Jan;40(1):125-131</RefSource><PMID Version="1">27815289</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ J. 2009 Mar;73(3):411-8</RefSource><PMID Version="1">19194043</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiovasc Diabetol. 2016 Aug 11;15(1):111</RefSource><PMID Version="1">27514514</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):498-508</RefSource><PMID Version="1">20042708</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Cardiol. 2016 Apr 1;117(7):1088-94</RefSource><PMID Version="1">26851962</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Macrovascular disease</Keyword><Keyword MajorTopicYN="N">Microvascular disease</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Type 2 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>05</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>07</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28750645</ArticleId><ArticleId IdType="doi">10.1186/s12933-017-0574-y</ArticleId><ArticleId IdType="pii">10.1186/s12933-017-0574-y</ArticleId><ArticleId IdType="pmc">PMC5530952</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Australie</li><li>France</li><li>Italie</li><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Londres</li><li>Lombardie</li><li>Nouvelle-Galles du Sud</li><li>Île-de-France</li></region><settlement><li>Londres</li><li>Milan</li><li>Paris</li><li>Sydney</li></settlement><orgName><li>University College de Londres</li><li>Université de Sydney</li></orgName></list><tree><country name="Australie"><region name="Nouvelle-Galles du Sud"><name sortKey="Mohammedi, Kamel" sort="Mohammedi, Kamel" uniqKey="Mohammedi K" first="Kamel" last="Mohammedi">Kamel Mohammedi</name></region><name sortKey="Chalmers, John" sort="Chalmers, John" uniqKey="Chalmers J" first="John" last="Chalmers">John Chalmers</name><name sortKey="Colagiuri, Stephen" sort="Colagiuri, Stephen" uniqKey="Colagiuri S" first="Stephen" last="Colagiuri">Stephen Colagiuri</name><name sortKey="Cooper, Mark" sort="Cooper, Mark" uniqKey="Cooper M" first="Mark" last="Cooper">Mark Cooper</name><name sortKey="Harrap, Stephen" sort="Harrap, Stephen" uniqKey="Harrap S" first="Stephen" last="Harrap">Stephen Harrap</name><name sortKey="Woodward, Mark" sort="Woodward, Mark" uniqKey="Woodward M" first="Mark" last="Woodward">Mark Woodward</name><name sortKey="Zoungas, Sophia" sort="Zoungas, Sophia" uniqKey="Zoungas S" first="Sophia" last="Zoungas">Sophia Zoungas</name></country><country name="France"><region name="Île-de-France"><name sortKey="Marre, Michel" sort="Marre, Michel" uniqKey="Marre M" first="Michel" last="Marre">Michel Marre</name></region></country><country name="Italie"><region name="Lombardie"><name sortKey="Mancia, Giuseppe" sort="Mancia, Giuseppe" uniqKey="Mancia G" first="Giuseppe" last="Mancia">Giuseppe Mancia</name></region></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Poulter, Neil" sort="Poulter, Neil" uniqKey="Poulter N" first="Neil" last="Poulter">Neil Poulter</name></region><name sortKey="Williams, Bryan" sort="Williams, Bryan" uniqKey="Williams B" first="Bryan" last="Williams">Bryan Williams</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F57 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000F57 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:28750645
|texte= Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:28750645" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |